NewLimit
Developing epigenetic reprogramming medicines to extend human healthspan.
Company facts
- Founded
- 2021
- Employees
- 50
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $45M · 2025
Open positions
1 job
Executive Assistant
Open 139d 5 months ago32 viewsNo extra questions
United States
South San FranciscoAbout NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful…
Business Development